If you are a member of the media and would like more information about Mylan Specialty, please contact our Global Communications Department at Mylan, our parent company, at 724-514-1968.
The news releases on this page are included for historical purposes only. The information contained in each press release speaks only of the date thereof and assumes no duty to update such information beyond the date thereof.
EpiPen®, EpiPen Jr®, EpiPen 2-Pak®, and EpiPen Jr 2-Pak® are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary, Mylan Specialty L.P.